Cytek Biosciences (CTKB) news
Recent news
Cyient - Announces formation of intelligent engineering solutions business unit
Cyient has announced the formation of a new business unit focused on intelligent engineering solutions, aligning with its recently unveiled brand positioning, "Nothing Less" brand positioning . This strategic move reflects the company's evolution into a global lifecycle engineering services…
AInvest Wire · Oct 6, 2026Cytex Biosciences: Sysmex & Cytex to offer integrated end-to-end flow cytometry solutions
Cytek Biosciences, a leader in cell analysis solutions, is expanding its product portfolio and market reach through strategic developments in flow cytometry technology. The company has introduced a range of full spectrum flow cytometry systems, including the Northern Lights™ and Aurora™ Evo, which…
AInvest Wire · Sep 9, 2026Sysmex Europe and Cytek Biosciences collaborate to expand access to advanced clinical flow cytometry
AInvest Wire · Sep 9, 2026CyteK Biosciences: jury awarded past damages consisting of $20 mln in lost profits and $36 mln in royalties
AInvest Wire · Aug 21, 2026CyteK Biosciences: jury finds in CyteK’s favor on three of four asserted claims; to challenge remaining finding
In a recent patent litigation case, Beckman Coulter, Inc. v. Cytek Biosciences, Inc., a jury found in favor of Cytek Biosciences on three of the four asserted claims. The decision, reached in the U.S. District Court for the District of Delaware (C.A. No. 24-945-CFC), marks a significant development…
AInvest Wire · Aug 21, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.
